Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

38.72
Delayed Data
As of Jan 20
 -0.03 / -0.08%
Today’s Change
37.20
Today|||52-Week Range
45.58
+0.55%
Year-to-Date
Better Buy: GlaxoSmithKline PLC vs. Johnson & Johnson
Jan 21 / MotleyFool.com - Paid Partner Content
Is GlaxoSmithKline's Stock a Bargain After Dropping 4.8% in 2016?
Jan 13 / MotleyFool.com - Paid Partner Content
5 Drugs That Are Way Cheaper in Canada
Jan 21 / MotleyFool.com - Paid Partner Content
4 Signs Glaxo's Turnaround Is Taking Hold
Jan 13 / MotleyFool.com - Paid Partner Content
Is GlaxoSmithKline (GSK) a Great Stock for Value Investors?
Jan 20 / Zacks.com - Paid Partner Content
Merck: Keytruda+Chemo Gets Priority Review for Lung Cancer
Jan 11 / Zacks.com - Paid Partner Content
Frontrunning: January 20
Jan 20 / Investing Channel - Paid Partner Content
3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock
Jan 10 / MotleyFool.com - Paid Partner Content
Flood of News Presents Buying Opportunity
Jan 17 / GuruFocus News - Paid Partner Content
Bristol-Myers, GeneCentric Tie Up for Opdivo Biomarker Study
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close38.75
Today’s open38.67
Day’s range38.55 - 38.75
Volume2,249,977
Average volume (3 months)3,625,991
Market cap$95.1B
Dividend yield5.39%
Data as of 4:01pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+11.48%
Earnings growth (next 5 years)+13.26%
Revenue growth (last year)-3.66%
P/E ratio345.7
Price/Sales2.70
Price/Book12.43

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.23-0.37%
CELGCelgene-0.96-0.84%
SNYSanofi+0.18+0.45%
LLYEli Lilly and Co-0.03-0.04%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs